Verdict91/ 100
Grade A− · #2Eden
A polished, high-disclosure compounded program with strong nationwide coverage.
Visit EdenHead-to-head verdict
Eden vs Gala Health
Two GLP-1 providers, compared side by side on The Verdict Score — our published six-factor rubric. Same yardstick, and no score is adjusted for payment.
Published by The GLP-1 Verdict
Pricing sources checked: Eden: October 2026 · Gala Health: October 2026
vs
Verdict86/ 100
Grade B · #7Gala Health
A women-focused compounded GLP-1 program with menopause and hormone care in the same app, a brand-Ozempic path and nationwide coverage — but the plan length behind its from-prices only appears at checkout.
Visit Gala HealthThe verdict
Winner: Eden
Eden takes it with a higher Verdict Score — 91/100 to 86/100 (grade A− vs B). People who want one flat price at every dose, with no membership fee, from a high-disclosure provider. Gala Health still earns its place — women in any state who want a compounded GLP-1 and hormone or menopause care from one prescriber, with a brand-name option on the table.
The score compares published program terms and features; it does not measure clinical outcomes or predict which treatment will suit you.
Our featured partner is CoreAge Rx (94/100) — the most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
Factor by factor
Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.
90Real-world results85
90
Real-world results85
89Price honesty87
89
Price honesty87
95Prescriber access88
95
Prescriber access88
86Formulary choice88
86
Formulary choice88
90Cancellation fairness84
90
Cancellation fairness84
92Member support84
92
Member support84
Price, coverage & features
| Metric | Eden | Gala Health |
|---|---|---|
| Verdict Score | 91/100 | 86/100 |
| Grade | A− | B |
| Semaglutide | $99/mo | From $129/mo (compounded) |
| Tirzepatide | $129/mo | From $179/mo (compounded) |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | No | No |
Eden
What we like
- High verification confidence — clear supply-chain and clinician disclosure
- Nationwide availability
- Both molecules offered
The caveats
- Compounded only — no brand-name access
Gala Health
What we like
- Advertised from $129/mo semaglutide and $179/mo tirzepatide (plan length set at checkout), with all doses included, so titrating up costs nothing extra
- Available in all 50 states, so access never blocks the sign-up
- Offers a real FDA-approved brand path (Ozempic) alongside the compounded track, which most compounded-only programs cannot
- Adjacent HRT and menopause care for patients who want more than a GLP-1 alone
The caveats
- No month-to-month price is published: the $129 and $179 from-prices don't say which plan length unlocks them, and Gala's FAQ starts plans at $199/mo on a three-month plan
- The $149 'microdose' tier is sub-therapeutic — a longevity protocol, not a cheaper weight-loss dose
- GLP-1 is compounded, not FDA-approved — the standard verification caveat applies
- Brand Ozempic runs $1,299/mo, and the dispensing pharmacy is never named — vet it yourself
- No refund when you cancel unless a provider medically disqualifies you, and cancellation needs 72 hours' notice before billing
Our pick — visit
People who want one flat price at every dose, with no membership fee, from a high-disclosure provider.
Visit Eden Read the full Eden review →Also worth a look
Women in any state who want a compounded GLP-1 and hormone or menopause care from one prescriber, with a brand-name option on the table.
Visit Gala Health Read the full Gala Health review →Keep comparing
Neither of these has to be the answer: the rivals we rank against Eden cover the 7 programs closest to it, and the same shortlist for Gala Health does the reverse.
More on Eden
Or browse the full comparison hub, every head-to-head A to Z and the complete rankings.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.